A University of Saskatchewan (U of S) research team has discovered a way to prevent bacteria from developing resistance to antibiotics, potentially helping to blunt the edge of a looming threat to public health around the world.
Ron Geyer
A University of Saskatchewan (U of S) research team has discovered a way to prevent bacteria from developing resistance to antibiotics, potentially helping to blunt the edge of a looming threat to public health around the world.
“Bacteria have a remarkable ability to acquire resistance against antibiotics,” says U of S biochemist Ron Geyer, who led the study published today in the journal Cell Chemical Biology. “We need new strategies to block development of resistance and to prolong the life of antibiotics, and we believe our work has revealed a promising direction.”
It’s an urgent problem. In 2014, the World Health Organization reported that antibiotic resistance “is now a major threat to public health,” and warned of a return to a pre-antibiotic era, where “common infections and minor injuries which have been treatable for decades can once again kill.”
The U of S team looked at the “SOS response,” which happens when bacteria are attacked by antibiotics. The bacterial cell stops its normal cycle in order to repair its DNA. The process is quite error-prone, so there are a lot of mutations-plus the response allows the bacteria to pick up genes from other bacteria in a process called horizontal gene transfer.
Since there are millions of bacteria, there are bound to be a few whose mutations that make some of them resistant to antibiotics. These resistant bacteria survive and multiply.
Geyer and his team looked at the molecular “switching system” for the SOS response-the RecA enzyme that turns it on, and the LexA enzyme that keeps it turned off. The team developed compounds that inhibit the RecA “on” switch. This prevented the SOS response, made the antibiotics more effective, reduced mutations, and blocked horizontal gene transfer.
The team tested the RecA inhibitors both with a variety of lab bench assays and in mice against several bacteria, including two that are notorious for multi-drug resistance: Pseudomonas aeruginosa and Staphylococcus aureus.
“Our results suggest the inhibitors should be useful with a broad spectrum of bactericidal antibiotics in Gram-negative or Gram-positive bacteria,” Geyer says.
He cautioned that much work remains to be done, for example, to tailor methods to better deliver RecA inhibitors.
The U of S has applied for a patent for the RecA inhibitor technology and is currently seeking partners to license and develop it. The work is supported by the Natural Sciences and Engineering Research Council of Canada.
Source: University of Saskatchewan
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.